biomee ApS: Financial statements 2024
CVR: 29829586
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
biomee ApS (CVR 29829586) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,444,339 and a net result of DKK 5,547,134 compared with DKK 7,867,031 the year before. That is a decrease of 40.9% compared with the year before. Equity in the 2024 report amounted to DKK 17,224,093. The solvency ratio was 92.7%.
- Gross Profit
- DKK 4,444,339
- Profit/Loss
- DKK 5,547,134
- Equity
- DKK 17,224,093
- Total Assets
- DKK 18,573,855
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.4 mio. | 5.5 mio. | 17.2 mio. | - |
| 2023 | - | 7.5 mio. | 7.9 mio. | 11.7 mio. | - |
| 2022 | - | 3.6 mio. | 3.6 mio. | 3.8 mio. | - |
| 2021 | - | 8.6 mio. | 7.8 mio. | 208 t. | - |
| 2020 | - | -461 t. | -2.8 mio. | -57.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Biomee ApS has published its annual report for 2023. Gross profit came to DKK 7,518,821, and the net result was DKK 7,867,031.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity in the 2025 report amounted to DKK 23,772,837.